A phase I study of XEN D0101 for the prevention of atrial fibrillation.

Trial Profile

A phase I study of XEN D0101 for the prevention of atrial fibrillation.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2011

At a glance

  • Drugs XEN D0101 (Primary)
  • Indications Atrial fibrillation
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top